Women with Lynch syndrome due to MLH1 pathogenic variants have an increased risk of specific cancers, including cancer of the colon or rectum (52–82%), uterus (25–60%), ovary (4–24%), stomach, urinary tract, pancreas, small bowel, hepatobiliary tract, and brain [7–9, 12–19]. This evidence concerns the gene MLH1 and Lynch syndrome.